RankingsPricing
  1. US-listed companies
  2. AbbVie Inc.
  3. Financials
  4. Cash from financing

AbbVie Inc.ABBV

Market cap
$405.4B
P/E ratio
SummaryFinancials
Period EndCash from financing (Million USD)YoY (%)
Dec 31, 2024-5,211-69.74%
Dec 31, 2023-17,222-30.56%
Dec 31, 2022-24,803+30.27%
Dec 31, 2021-19,039+65.54%
Dec 31, 2020-11,501-161.48%
Dec 31, 201918,708-229.95%
Dec 31, 2018-14,396+161.18%
Dec 31, 2017-5,512+40.33%
Dec 31, 2016-3,928-168.29%
Dec 31, 20155,752-274.67%
Dec 31, 2014-3,293-4.33%
Dec 31, 2013-3,442

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)